These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 27681880)

  • 61. The impact of medicaid status on outcome after gastric bypass.
    Alexander JW; Goodman HR; Martin Hawver LR; James L
    Obes Surg; 2008 Oct; 18(10):1241-5. PubMed ID: 18618206
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Economic evaluation of surgical treatment of obesity.
    Rodicio Miravalles JL; Alonso Fernández J; Moreno Gijón M; Rizzo Ramos A; Turienzo Santos E; Sanz Álvarez L; Rodríguez García JI; González González JJ
    Cir Esp (Engl Ed); 2020; 98(7):381-388. PubMed ID: 32139086
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comment on: Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery.
    Iannelli A; Schneck AS; Gugenheim J
    Surg Obes Relat Dis; 2011; 7(5):625-7. PubMed ID: 21659007
    [No Abstract]   [Full Text] [Related]  

  • 64. Lipedema in patients after bariatric surgery.
    Bast JH; Ahmed L; Engdahl R
    Surg Obes Relat Dis; 2016 Jun; 12(5):1131-1132. PubMed ID: 27317598
    [No Abstract]   [Full Text] [Related]  

  • 65. [French comment on article Purse-string transoral outlet reduction (TORe) is effective at inducing weight loss and improvement in metabolic comorbidities after Roux-en-Y gastric bypass].
    Endoscopy; 2018 Apr; 50(4):459-460. PubMed ID: 29587331
    [No Abstract]   [Full Text] [Related]  

  • 66. Gastric bypass--a combined restrictive and malabsorbtive procedure or a malabsorbtive procedure alone?
    O'Dea J
    Surg Obes Relat Dis; 2013; 9(1):151. PubMed ID: 22939279
    [No Abstract]   [Full Text] [Related]  

  • 67. Reply: Gastric bypass--a combined restrictive and malabsorbtive procedure or a malabsorbtive procedure alone?
    Heneghan HM; Brethauer SA; Chand B
    Surg Obes Relat Dis; 2013; 9(1):152-3. PubMed ID: 23357104
    [No Abstract]   [Full Text] [Related]  

  • 68. Reduction in Comorbid Conditions Over 5 Years Following Bariatric Surgery in Medicaid and Commercially Insured Patients.
    Takemoto E; Wolfe BM; Nagel CL; Boone-Heinonen J
    Obesity (Silver Spring); 2018 Nov; 26(11):1807-1814. PubMed ID: 30358155
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Re: Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity.
    Kaidar-Person O; Rosenthal RJ
    J Gastrointest Surg; 2008 Feb; 12(2):397. PubMed ID: 18043986
    [No Abstract]   [Full Text] [Related]  

  • 70. Comment on: Early prediction of the failure to lose weight after obesity surgery.
    Papasavas P
    Surg Obes Relat Dis; 2013; 9(1):121-2. PubMed ID: 22206614
    [No Abstract]   [Full Text] [Related]  

  • 71. Comment on: Risk stratification of serious adverse events after gastric bypass in the Bariatric Outcomes Longitudinal Database.
    Finks JF
    Surg Obes Relat Dis; 2012; 8(6):677-8. PubMed ID: 23041428
    [No Abstract]   [Full Text] [Related]  

  • 72. Are we pricing ourselves out of the market in bariatric surgery?
    Jones KB
    Obes Surg; 2011 Jul; 21(7):928-9. PubMed ID: 21484525
    [No Abstract]   [Full Text] [Related]  

  • 73. Pay Status as a Predictor of Outcome in Surgical Treatment of Obesity.
    Renquist KE; Mason EE; Tang S; Cullen JJ; Doherty C; Maher JW
    Obes Surg; 1996 Jun; 6(3):224-232. PubMed ID: 10729863
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The association of obesity with health insurance coverage and demographic characteristics: a statewide cross-sectional study.
    Mylona EK; Benitez G; Shehadeh F; Fleury E; Mylonakis SC; Kalligeros M; Mylonakis E
    Medicine (Baltimore); 2020 Jul; 99(27):e21016. PubMed ID: 32629722
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Variation in Weight and Obesity Comorbidities After Open Roux-en-Y Gastric Bypass by Health Insurance: Medicaid vs Medicare vs Private vs Self-Pay in 4225 Bariatric Outcomes Longitudinal Database Patients.
    Davis M; Gomez J; Sheck C; Slotman G
    JAMA Surg; 2017 Jan; 152(1):105-109. PubMed ID: 27681880
    [No Abstract]   [Full Text] [Related]  

  • 76. In the superobese, weight loss and resolution of obesity comorbidities after biliopancreatic bypass and/or duodenal switch vary according to health insurance carrier: Medicaid vs Medicare vs Private insurance vs Self-Pay in 1681 Bariatric Outcomes Longitudinal Database patients.
    Gomez JP; Davis MA; Slotman GJ
    Am J Surg; 2016 Mar; 211(3):519-24. PubMed ID: 26739769
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of Medicaid status on weight loss, hospital length of stay, and 30-day readmission after laparoscopic Roux-en-Y gastric bypass surgery.
    Jensen-Otsu E; Ward EK; Mitchell B; Schoen JA; Rothchild K; Mitchell NS; Austin GL
    Obes Surg; 2015 Feb; 25(2):295-301. PubMed ID: 25022673
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ten-year outcomes of Roux-en-Y gastric bypass are equivalent in patients with Medicare disability and non-Medicare patients.
    Michaels AD; Mehaffey JH; Hawkins RB; Meneveau MO; Schirmer BD; Hallowell PT
    Surgery; 2018 Oct; 164(4):905-908. PubMed ID: 30087045
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Catabolic effects of gastric bypass in a diet-induced obese rat model.
    Guijarro A; Kirchner H; Meguid MM
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):423-35. PubMed ID: 16778572
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Laparoscopic versus open gastric bypass.
    Nguyen NT; Wolfe BM
    Semin Laparosc Surg; 2002 Jun; 9(2):86-93. PubMed ID: 12152151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.